KAITLYN WILSON: Open Payments
NPI 1508550591 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,280 in 158 payments from 41 companies in 2025. Trend: 2023 $998 · 2024 $2,946 · 2025 $3,280
Food & beverage: $3,106Education: $174
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $451 |
| AstraZeneca Pharmaceuticals LP | 15 | $294 |
| PFIZER INC. | 13 | $175 |
| Merck Sharp & Dohme LLC | 7 | $140 |
| Genentech USA, Inc. | 6 | $130 |
| Incyte Corporation | 7 | $128 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Daiichi Sankyo Inc. | 5 | $119 |
| Exelixis Inc. | 5 | $107 |
| GlaxoSmithKline, LLC. | 5 | $102 |
Products named: ENHERTU, DARZALEX, KEYTRUDA, CABOMETYX, CARVYKTI, ERLEADA, RYBREVANT, OPDIVO.
Industry payments across KS — which companies pay providers there.
